Celiac Disease
Anti-TTG and Endomysium IgA: a commonly used celiac disease screening.
Every result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
Endomysium IgA provides highly specific confirmation of coeliac disease when used alongside anti-TTG screening. Including both markers in a preventive panel ensures comprehensive coeliac assessment.
This test detects IgA antibodies directed against endomysial tissue. It is one of the most specific tests for coeliac disease, with a specificity approaching 100% in experienced laboratories. It is often used to confirm positive anti-TTG results.
Due to its very high specificity, a positive endomysium IgA result strongly supports a diagnosis of coeliac disease. This helps healthcare providers decide on further management including potential biopsy and dietary intervention.
Endomysium IgA is typically ordered alongside or after anti-TTG testing to confirm coeliac disease. You must be consuming gluten regularly at the time of testing. Consult your healthcare provider for guidance on when this test is appropriate.
If coeliac disease is confirmed, a strict gluten-free diet is essential. Gluten is found in wheat, barley, and rye. Reading food labels carefully and working with a dietitian ensures nutritional adequacy while avoiding gluten.
This marker is included in the following test panels.
Anti-TTG and Endomysium IgA: a commonly used celiac disease screening.